Novavax Inc. closed 73.09% below its 52-week high of $23.86, which the company achieved on June 6th.

Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Novavax is expected to post earnings of $0.19 ...

empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For Novavax, the consensus EPS estimate for the quarter has ...

Novavax, Inc. (Nasdaq: NVAX) today announced the appointment of Charles Newton to its board as an independent director. Mr.

$170,000 of NOVAVAX INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues related to COVID-19 vaccines ...

The U.S. FDA is asking Novavax (NASDAQ:NVAX) to conduct an additional randomized, controlled study of its COVID-19 vaccine ...

Novavax (NASDAQ: NVAX) shares declined 6% following a report from the Wall Street Journal that said federal regulators are ...

Shares of Novavax (NASDAQ:NVAX) rose on Wednesday after the company revealed U.S. FDA's request for additional clinical data ...

Novavax (NasdaqGS:NVAX) recently announced preliminary results from its SHIELD-Utah study, showcasing the Novavax COVID-19 vaccine's effectiveness and reduced side effects compared to a competitor's ...

Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...